GGrantIndex
← Leaderboards

Jonathan David Glass

Johns Hopkins University

$5,902,513
Attributed
$7,805,579
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $987K · FY200624
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$7,805,579 · 12

By mechanism

R01$2,537,421 · 1
P30$2,169,069 · 3
P50$1,730,359 · 2
R21$747,133 · 2
P01$596,597 · 3
R03$25,000 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNeurodegenerative DisordersSpinal CordAutopsyS DiseaseAmyotrophic Lateral SclerosisResearch PersonnelInnovationTissuesBrain DiseasesDesignResearch StudyProgramsProteomicsNeuropathologyDementiaMissionTissue BanksHarvestLinkClassificationHuman TissueResearch Project GrantsDiagnosis

Grant awards (34)

Emory Alzheimer's Disease Research Center$383,484
P30 · FY2024 · AG · contact PI
Emory Alzheimer's Disease Research Center$591,439
P30 · FY2023 · AG · contact PI
Emory Alzheimer's Disease Research Center$381,205
P30 · FY2022 · AG · contact PI
Emory Alzheimer's Disease Research Center$398,521
P30 · FY2021 · AG · contact PI
Emory Alzheimer's Disease Research Center$414,420
P30 · FY2020 · AG · contact PI
D: Neuropathology Core$226,845
P50 · FY2019 · AG · contact PI
D: Neuropathology Core$231,193
P50 · FY2018 · AG · contact PI
D: Neuropathology Core$195,222
P50 · FY2017 · AG · contact PI
D: Neuropathology Core$185,935
P50 · FY2016 · AG · contact PI
Phase 1b Trial of stem cells in ALS$709,886
R01 · FY2015 · NS · contact PI
D: Neuropathology Core$185,935
P50 · FY2015 · AG · contact PI
Phase 1b Trial of stem cells in ALS$54,673
R01 · FY2015 · NS · contact PI
Phase 1b Trial of stem cells in ALS$36,505
R01 · FY2015 · NS · contact PI
Phase 1b Trial of stem cells in ALS$577,888
R01 · FY2014 · NS · contact PI
NEUROPATHOLOGY CORE$133,045
P50 · FY2014 · AG · contact PI
Phase 1b Trial of stem cells in ALS$562,841
R01 · FY2013 · NS · contact PI
NEUROPATHOLOGY CORE$141,318
P50 · FY2013 · AG · contact PI
Phase 1b Trial of stem cells in ALS$595,628
R01 · FY2012 · NS · contact PI
NEUROPATHOLOGY CORE$135,118
P50 · FY2012 · AG · contact PI
NEUROPATHOLOGY CORE$157,626
P50 · FY2011 · AG · contact PI
NEUROPATHOLOGY CORE$138,122
P50 · FY2010 · AG · contact PI
Proteomic Markers for ALS$167,344
R21 · FY2008 · NS · contact PI
Proteomic Markers for ALS$200,813
R21 · FY2007 · NS · contact PI
Axonal Protection for Multiple Sclerosis$197,742
R21 · FY2007 · NS · contact PI
Discovering Calpain Inhibitors for Neurological Diseases$25,000
R03 · FY2007 · DA · contact PI
Axonal Protection for Multiple Sclerosis$181,234
R21 · FY2006 · NS · contact PI
Mechanisms of axonal degeneration$55,743
P01 · FY2002 · NS
Core--Histology$55,741
P01 · FY2002 · NS
UV light and the cutaneous neurosensory system$0
P30 · FY2002 · AR
Mechanisms of axonal degeneration$55,743
P01 · FY2001 · NS
Core--Histology$55,741
P01 · FY2001 · NS
NEUROMA RESECTION AND ADRIAMYCIN$262,145
P01 · FY2000 · HD
Mechanisms of axonal degeneration$55,743
P01 · FY2000 · NS
Core--Histology$55,741
P01 · FY2000 · NS